論文

国際誌
2018年10月

miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.

Anticancer research
  • Takaki Akamine
  • ,
  • Yosuke Morodomi
  • ,
  • Yui Harada
  • ,
  • Koji Teraishi
  • ,
  • Tetsuzo Tagawa
  • ,
  • Tatsuro Okamoto
  • ,
  • Yoshihiko Maehara
  • ,
  • Yoshikazu Yonemitsu

38
10
開始ページ
5693
終了ページ
5701
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.21873/anticanres.12906

BACKGROUND/AIM: Alterations of microRNA expression in three-dimensional spheroids were examined to identify novel microRNAs that might be associated with tumorigenesis. MATERIALS AND METHODS: Using microRNA microarray analysis, we screened for microRNAs that were dramatically up-regulated inside three-dimensional spheroids in genetically-modified HCT116 human colon cancer cells expressing Copepoda Green Fluorescent Protein under hypoxia. RESULTS: miR-3148 was identified as a possible candidate onco-microRNA. A growth advantage of HCT116 cells stably expressing miR-3148 (HCT116-miR3148) was observed compared to parental cells in vivo, but not in vitro. Additionally, no change in growth under hypoxic or starvation conditions was seen in these cells cultured two-dimensionally; however, HCT116-miR3148 cells maintained as three-dimensional spheroids were highly resistant to hypoxic conditions. HCT116-miR3148 cells were more sensitive to mitogen-activated protein kinase (MAPK) kinase inhibitors and extracellular signal-regulated kinase (ERK) inhibitors. CONCLUSION: MiR-3148 may be a novel onco-microRNA that protects cancer cells from serious stress conditions through the MAPK/ERK pathway, especially in vivo.

リンク情報
DOI
https://doi.org/10.21873/anticanres.12906
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/30275189
ID情報
  • DOI : 10.21873/anticanres.12906
  • PubMed ID : 30275189

エクスポート
BibTeX RIS